Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Retail trading hits snags as vaccine news sparks stock scramble

Published 11/09/2020, 11:15 AM
Updated 11/09/2020, 05:50 PM
© Reuters. 2020 U.S. presidential election in New York

© Reuters. 2020 U.S. presidential election in New York

By Muvija M and Noor Zainab Hussain

(Reuters) - Stock trading volumes on retail platforms hit record levels on Monday, although the impact of positive news about Pfizer 's (N:PFE) experimental COVID-19 vaccine triggered problems for clients of some major brokerages.

Equities rallied after the first successful data from a large-scale clinical trial of a coronavirus vaccine caused a stampede to buy stocks.

However, some retail traders said technical difficulties meant they had missed out on the rally.

Monitoring website Downdetector.com said customers of Merrill Lynch, Fidelity, Charles Schwab Corp (N:SCHW), TD Ameritrade (MX:AMTD) and Vanguard had problems logging in or placing orders.

Charles Schwab and TD Ameritrade acknowledged issues with their platforms and later said in statements posted on Twitter that they have been resolved.

A spokesman for Bank of America's (N:BAC) Merrill Lynch said it had not experienced an outage after Downdetector.com said more than 1,000 clients reported problems logging into Merrill Lynch accounts within the first two hours of trading.

Vanguard did not immediately respond to a request for comment.

A spokesman for IG Group (L:IGG) said "unprecedented" trading volumes in the 30 minutes after the Pfizer announcement were up to 10 times the level seen earlier in the day and broke a previous record set in March when markets recorded sharp falls at the peak of virus-related restrictions.

Retail brokers, which have been under scrutiny for outages, spent months shoring up their platforms in preparation for record volumes following the election, but the latest pandemic related development proved to be a harder test.

"It's unthinkable that a piece of news could eclipse the result of a U.S. Presidential election, but Pfizer's vaccine results have done just that," said AJ Bell analyst Laith Khalaf.

"The stock market is experiencing a serious melt-up, and safe havens like gold and bonds have sold off."

Oil prices, which plunged into negative territory in April, rose by nearly 10% and global stocks scaled record highs after Pfizer and German partner BioNTech (O:BNTX) said that based on initial trial results their experimental vaccine was more than 90% effective in preventing COVID-19. [O/R]

Retail participation in the equities markets has surged since March, as shares soared in response to government stimulus aimed at countering the coronavirus' economic impact.

Traders rushed to stocks hit by the pandemic, including oil companies, hospitality groups, fashion retailers and airlines.

In what could perhaps be the clearest sign that markets are counting on life getting back to normal, shares in cinema operators AMC (N:AMC) and Cineworld (L:CINE) rose by about 40%.

Hargreaves Lansdown (L:HRGV), a fund and trading platform with more than 1.4 million investors, said the trial results prompted the busiest day in volumes on its website and app.

(GRAPHIC: Trading volumes surge amid COVID-19 pandemic - https://fingfx.thomsonreuters.com/gfx/buzz/rlgvdamojpo/Pasted%20image%201604938906380.png)

© Reuters. 2020 U.S. presidential election in New York

Latest comments

I never believe the hiccups in log in is accident, I learnt before the stock exchange has been executing queue label type system. Some brokers has never had any problem logging in exchange! Grow up, man!
The era of insanity. 1929.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.